| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Sales and other operating revenues | 7,197 | 7,091 | 7,727 | 7,658 |
| Cost of sales | 6,496 | 6,756 | 6,821 | 6,871 |
| Goodwill impairments | NaN | 131* | 972 | NaN |
| Impairments | 15 | -114* | 230 | 32 |
| Selling, general and administrative expenses | 411 | 373 | 401 | 435 |
| Research and development expenses | 36 | 33 | 34 | 35 |
| Operating costs and expenses | 6,958 | 7,179 | 8,458 | 7,373 |
| Operating income | 239 | -88 | -731 | 285 |
| Interest expense | 138 | 132 | 130 | 118 |
| Interest income | 31 | 25 | 21 | 21 |
| Loss (gain) on sale of business | NaN | 0 | -6 | 0 |
| Other income, net | 10 | 65 | -2 | 29 |
| Income from continuing operations before equity investments and income taxes | 142 | -130 | -848 | 217 |
| Income (loss) from equity investments | -5 | -12 | -8 | 7 |
| Income from continuing operations before income taxes | 137 | -142 | -856 | 224 |
| Income tax at u.s. statutory rate | NaN | -63* | NaN | NaN |
| State and local income tax, net of federal income tax effect | NaN | 4* | NaN | NaN |
| Change in deferred tax on outside basis differences | NaN | -3* | NaN | NaN |
| Deemed income inclusion | NaN | 3* | NaN | NaN |
| Deduction of non-u.s. taxes paid | NaN | 3* | NaN | NaN |
| Tax credits | NaN | 1* | NaN | NaN |
| Export incentive | NaN | -11* | NaN | NaN |
| Other | NaN | 3* | NaN | NaN |
| Other adjustments | NaN | -0* | NaN | NaN |
| Nondeductible impairment-CN | NaN | 3* | NaN | NaN |
| Other adjustments-CN | NaN | 2* | NaN | NaN |
| Nondeductible impairment-FR | NaN | 4* | NaN | NaN |
| Statutory income tax rate differential-FR | NaN | 2* | NaN | NaN |
| State and local income tax, net of federal income tax effect-DE | NaN | -8* | NaN | NaN |
| Tax refund claim | NaN | -6* | NaN | NaN |
| Change in deferred tax on outside basis differences-DE | NaN | -6* | NaN | NaN |
| Changes in valuation allowances-DE | NaN | 4* | NaN | NaN |
| Statutory income tax rate differential-DE | NaN | 3* | NaN | NaN |
| Other adjustments-DE | NaN | -1* | NaN | NaN |
| Nondeductible impairment-IT | NaN | 2* | NaN | NaN |
| Other adjustments-IT | NaN | 1* | NaN | NaN |
| Statutory income tax rate differential-MT | NaN | -25* | NaN | NaN |
| Nondeductible impairment-MX | NaN | 8* | NaN | NaN |
| Other adjustments-MX | NaN | 1* | NaN | NaN |
| Nondeductible impairment-NL | NaN | 31* | NaN | NaN |
| Foreign currency gain or loss | NaN | 16* | NaN | NaN |
| Changes in valuation allowances-NL | NaN | 3* | NaN | NaN |
| Other adjustments-NL | NaN | 3* | NaN | NaN |
| Statutory income tax rate differential-NL | NaN | 2* | NaN | NaN |
| Changes in valuation allowances-GB | NaN | 21* | NaN | NaN |
| Other adjustments-GB | NaN | 2* | NaN | NaN |
| Statutory income tax rate differential-Foreign Tax Jurisdiction Other | NaN | 2* | NaN | NaN |
| Changes in unrecognized tax benefits | NaN | 1* | NaN | NaN |
| Provision for (benefit from) income taxes | -2 | -8 | -27 | 69 |
| Income from continuing operations | 139 | -134 | -829 | 155 |
| Sales and other operating revenues | NaN | 265 | 293 | 326 |
| Cost of sales | NaN | 331 | 331 | 369 |
| Other impairments | NaN | 0 | NaN | NaN |
| Selling, general and administrative expenses | NaN | 1 | 1 | 2 |
| Operating income (gain) | NaN | -67 | -39 | -45 |
| Other income (expense), net | NaN | 62 | -44 | -2 |
| Provision for (benefit from) income taxes | NaN | 1 | -22 | -7 |
| Income (gain) from discontinued operations, net of tax | -14 | -6 | -61 | -40 |
| Net income | 125 | -140 | -890 | 115 |
| Basic EPS | 0.38 | -0.438 | -2.77 | 0.34 |
| Diluted EPS | 0.38 | -0.438 | -2.77 | 0.34 |
| Basic Average Shares | 322,000,000 | 320,000,000 | 322,000,000 | 322,000,000 |
| Diluted Average Shares | 323,000,000 | 320,000,000 | 322,000,000 | 322,000,000 |
LyondellBasell Industries N.V. (LYB)
LyondellBasell Industries N.V. (LYB)